BN Business News
أضف شركتك →
تجري حاليًا ترجمة هذا المقال. نعرض مؤقتًا النسخة الأصلية باللغة الإنجليزية.

الأعمال · 15‏/4‏/20151 دقائق للقراءة

Innovations in Medical Evidence Development and Surveillance-Methods Research Agenda

ترجمة آلية محلية · اللغة الأصلية للمصدر

الملخص

The Food and Drug Administration (FDA) is announcing the availability of grant funds for the support of Center for Drug Evaluation and Research (CDER). The goal of the CDER is to support the development of appropriate methodologies to conduct medical product safety surveillance in large electronic databases. Innovations in Medical Evidence Development and Surveillance (IMEDS)-Methods is a program within the Reagan-Udall Foundation that supports FDA's scientific mission of serving public health needs by initiating and facilitating research into the methods of safety evaluation in large databases.

اللغة الأصلية للمصدر: Federal Register — Food and Drug Administrationافتح البيان الأصلي →

استكشف الموضوعات

تحليلات الأعمال →